To Understand characteristics of Patients with Anaemia in Chronic Kidney Disease receiving Darbotin

Prospective Analysis of characteristics of Patients with Anaemia in CKD receiving DarbotinÃ¢â??Â¢

Status

Recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2021/07/035250

Enrollment

2200

Registered

2021-07-29

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R790- Abnormal level of blood mineral Health Condition 2: D631- Anemia in chronic kidney disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult patients (of age 18-80 years) with Anaemia in CKD prescribed with DarbotinÃ¢â??Â¢ 2. Patient willing to comply with the study protocol and written informed consent.

Exclusion criteria

Exclusion criteria: Patient not willing to comply with the study protocol and written informed consent.

Design outcomes

Primary

Measure	Time frame
eGFR level Hemoglobin levels Blood pressure measurements ESA statusTimepoint: Single Visit Study	—

Secondary

Measure	Time frame
Treatment pattern of DarbotinÃ¢â??Â¢:Dosage strength, frequency, route, dosage form, duration of treatmentTimepoint: Single Visit Study	—

Countries

India

Contacts

Public ContactDr Khokan Debnath

Wockhardt Ltd.

singole@wockhardt.com022-26596775

Outcome results